29. Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the NCI of Canada Clinical Trials Group (abstract 1). J Clinical Oncology 23 (suppl 16S): 1s, 2005.